Why the study?
Does uninterrupted edoxaban or rivaroxaban improve safety and efficacy compared to warfarin in patients undergoing AF/flutter ablation?
Does uninterrupted edoxaban or rivaroxaban improve safety and efficacy compared to warfarin in patients undergoing AF/flutter ablation?
Uninterrupted edoxaban, rivaroxaban, and warfarin appear to have comparable safety and efficacy profiles in patients undergoing atrial fibrillation or flutter ablation in a real-world setting.
Supports similar periprocedural use of these agents; leaves open need for randomized confirmation in AF ablation.
This real-world study demonstrated no significant difference in safety and efficacy between uninterrupted edoxaban, warfarin and rivaroxaban in patients undergoing AF/flutter ablation.
No takes yet. Share an insight, caveat, or question.
Narendra Kumar (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: